Pure Global
NCT06253325

Early Detection of At-risk Septic Patients

An Observational Pilot Study for the Multi-Modality Risk Prediction and Early Identification of Critically Ill Septic Patients in the Emergency Department
University Hospital Southampton NHS Foundation Trust·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Sepsis
Drug/Device/Intervention
Measuring tissue oxygenation
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
University Hospital Southampton NHS Foundation Trust
Location
Southampton, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Jan 12, 2024
End date
Aug 06, 2024
Enrollment
60 participants
Primary outcome

Differences in tissue oxygenation

Summary

The purpose of this study is to determine whether additional investigations used in other
 parts of healthcare can be used in the Emergency Department to identify critically ill
 patients quicker than usual care.

ICD-10 classifications
Other sepsisSepsis, unspecifiedOther specified sepsisCandidal sepsisPuerperal sepsis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06253325
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06253325 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Southampton NHS Foundation Trust and is currently Recruiting. The study focuses on Sepsis. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.